Related Experiment Video
Updated: Jun 14, 2026

Association Between Sleep Quality and Cognitive Symptoms in Patients with Major Depressive Disorder
Published on: April 26, 2024
Analysis of Classes Used in the Treatment of Depression by Physician-reported Severity
Susan Lenderts1, Amir H Kalali, Richard Weisler
1Ms. Lenderts is Manager, Strategic Analytics, Quintiles Commercial, Falls Church, Virginia.
Abstract:
We analyzed use of therapeutic drug classes for the treatment of depression by the three levels of physician-reported disease severity (mild, moderate, and severe) to understand if the mix of therapeutic classes used to treat depression changes as disease severity increases. Prior to analyzing drug uses in each severity category, we established that in the 12 months ending November 2009, the majority of patients (65%) were assigned a severity rating of 'moderate' by their physician; 27 percent and eight percent of patients were designated as 'mild' and 'severe,' respectively. In general, we found that as disease severity changes, so too do the proportions of the various therapeutic classes used in depression. The differences in class mix by severity have persisted at least since the 12 months ending December 2008, and it appears that the mix of drug classes used in severe depression are becoming less similar to the class mix for moderate depression over time.
Related Concept Videos
Antidepressant Drugs: MAOIs and Other Agents
Antidepressant Drugs: Overview
Depressive Disorders: MDD and Dysthymia
Depression: Overview
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
Diagnostic and Statistical Manual of Mental Disorders (DSM)
